Welcome to our dedicated page for Telus news (Ticker: TU), a resource for investors and traders seeking the latest updates and insights on Telus stock.
TELUS Corporation (NYSE: TU, TSX: T) generates frequent news across communications technology, digital health, agriculture, consumer goods and customer experience services. Company releases highlight its broadband connectivity operations, global expansion of TELUS Health, and the growth of TELUS Digital’s AI‑enabled customer experience platforms. Investors following TU news can track how these activities interact with the company’s capital allocation framework, deleveraging plans and shareholder return policies.
Recent announcements have focused on TELUS Health’s global scale and monetisation strategy, including the engagement of TD Securities and Jefferies as financial advisors to evaluate potential strategic partnerships. News has also covered TELUS leadership and board members purchasing additional shares, as well as share repurchases under a normal course issuer bid, which the company links to its view of the stock’s value and its long‑term growth prospects.
TELUS regularly issues updates on its financing activities, such as offerings of fixed‑to‑fixed rate junior subordinated notes in U.S. and Canadian dollars, cash tender offers for multiple series of long‑dated notes, and the redemption of specific note series. Quarterly results releases provide detail on operating revenue, adjusted EBITDA, free cash flow, subscriber growth across mobile and fixed services, and performance in TELUS Health and TELUS Digital.
On this TU news page, readers can review company‑issued press releases and related coverage, including items on network investments, partnerships like the Terrion wireless tower venture, analyst recognition of TELUS Digital’s CX transformation capabilities, and updates to dividend and dividend reinvestment plan policies. Regularly checking this feed helps investors and observers understand how TELUS’ operational performance, strategic initiatives and balance sheet actions evolve over time.
TELUS (TSX:TU) announced a quarterly cash dividend of $0.4184 CAD per common share, payable on April 1, 2026 to shareholders of record at the close of business on March 11, 2026. The declaration was made by the Board of Directors and signed by Andrea Wood, EVP and Chief Legal and Governance Officer, dated February 11, 2026.
Contact for investor inquiries is Investor Relations at 1-800-667-4871 or ir@telus.com.
TELUS (NYSE: TU) announced that long-time President and CEO Darren Entwistle will retire on June 30, 2026 after 26 years. The Board appointed Victor Dodig as President and CEO effective July 1, 2026; he becomes CEO designate immediately and will join full time on May 1, 2026.
Mr. Dodig served as CIBC CEO from 2014–2025, has been a TELUS director since May 2022, and Entwistle will act as advisor until April 30, 2027. TELUS reported operations across >45 countries and annual revenue of >$20 billion under Entwistle's tenure.
TELUS (NYSE:TU) reported strong Q4 and full-year 2025 results with industry-leading customer growth and clear 2026 targets. Key metrics: 377,000 Q4 net additions; full-year combined additions 1,081,000; consolidated operating revenue $5.3B in Q4; record consolidated Free Cash Flow $2.2B (up 11%); net debt/Adjusted EBITDA 3.4x at year-end.
The company set 2026 targets: Consolidated Service Revenues and Adjusted EBITDA +2–4%, Consolidated CapEx ≈ $2.3B, and Consolidated Free Cash Flow ≈ $2.45B.
TELUS Digital (NYSE: TU) released U.S. poll results and a research paper (Feb 11, 2026) finding that asking AI follow-up prompts like "Are you sure?" rarely improves accuracy. A 1,000-person poll found 60% asked follow-ups but only 14% saw answers change.
The Certainty Robustness Benchmark (200 math/reasoning items) tested GPT-5.2, Gemini 3 Pro, Claude Sonnet 4.5 and Llama-4, concluding follow-up prompts do not reliably raise LLM accuracy and can sometimes reduce it.
Abu Dhabi Health Data Services (M42) and TELUS Health (NYSE:TU) announced a strategic collaboration to deliver AI‑powered, personalized employee wellbeing solutions across the UAE and the region. The partnership will adapt a 40+ module Employee Assistance Program into local languages and explore next‑generation AI and precision medicine capabilities.
The initiative aims to reduce absenteeism, improve productivity and scale integrated digital health services using ADHDS infrastructure such as Malaffi, Sahatna and virtual hospital platforms.
TELUS (NYSE:TU) released its 2026 AI Trust Atlas showing broad AI adoption and strong calls for oversight. The survey of over 11,000 Canadians and Americans found 85% of Canadians and 89% of Americans use AI, while 90% in both countries support regulation.
Respondents emphasized reviewing AI for harms, plain-language explanations, and soliciting customer input to build trustworthy AI.
TELUS (NYSE: TU) and RingCentral announced an expansion of TELUS Business Connect to add advanced AI-powered conversational and automation features for Canadian businesses. The integrated capabilities include RingCentral AVA (real-time AI assistant), RingCentral AIR (AI Receptionist), RingCentral ACE (AI Insights), AI Chat, and RingCX contact center functionality across >20 digital channels. The update aims to automate routine tasks, improve customer interactions, and boost employee productivity without requiring technical expertise. The enhanced TELUS Business Connect platform will be available to customers in early 2026. For more information, visit telus.com/BusinessConnect.
TELUS (NYSE:TU) completed the full redemption of its outstanding C$600 million 3.75% Notes, Series CV due March 10, 2026 on Jan 16, 2026.
The redemption was funded by proceeds from TELUS' Dec 2025 offering of Fixed-to-Fixed Rate Junior Subordinated Notes (Hybrid Notes) that raised the equivalent of C$2.9 billion, with proceeds designated toward debt repayment. The company also early-redeemed seven series of discounted notes totaling C$1.0 billion in cash proceeds as part of broader deleveraging initiatives.
TELUS reports a projected 2025 net debt to adjusted EBITDA of ~3.4x and targets circa 3.3x by year-end 2026 and ~3.0x by end of 2027, citing improved balance sheet flexibility.
TELUS (NYSE: TU) has engaged TD Securities and Jefferies to advise on a monetisation and partnership strategy for TELUS Health.
TELUS Health serves over 160 million lives across 200+ countries and reported year-to-date operating revenue of $1.5 billion, EBITDA of $258 million, and cash flow of $99 million as of Q3 2025. TELUS said the monetisation may include strategic partnerships and is intended to support deleveraging: net debt to adjusted EBITDA is projected at ~3.4x for 2025, with targets of ~3.3x by year-end 2026 and 3.0x by end-2027. TELUS also targets a minimum 10% compounded annual free cash flow growth through 2028.
TELUS (TSX:TU) reported that members of its board and executive team, including CEO Darren Entwistle, purchased a total of 357,090 additional TELUS shares in November–December 2025, bringing insider holdings to about 2.4 million shares as of December 31, 2025. The company also purchased for cancellation 2,299,753 common shares at an average price of $17.3932 per share, representing an 18% discount to the 12‑month average, under a $500 million NCIB that commenced December 17, 2025.
TELUS reiterated targets of a minimum 10% CAGR in free cash flow through 2028 and net debt to adjusted EBITDA of ~3.3x by year‑end 2026 and 3.0x by end 2027, and said the CEO will continue taking his salary in TELUS shares.